A Study to Test the Effectiveness of Virulizin® Given in Combination With Standard Chemotherapy for Pancreatic Cancer
NCT00040092
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
400
Enrollment
INDUSTRY
Sponsor class
Conditions
Pancreatic Cancer
Interventions
DRUG:
Virulizin®
Sponsor
Aptose Biosciences Inc.